Cure Genetics Competitors and Similar CompaniesClear all
Zyngenia's competitors and similar companies include Reglagene and Exicure.
 Zyngenia Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways. |  Reglagene Reglagene is a company that discovers and develops noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment. |  Exicure Exicure is a biotechnology company developing immunomodulatory and gene regulating drugs against validated targets. | |
Founding Date | Founding Date 2009 | Founding Date 2016 | Founding Date 2011 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Washington, US HQ | Locations Tucson, US HQ | Locations Skokie, US HQ Chicago, US |
Employees | Employees N/A | Employees 14 | Employees 29 |
Funding | |||
Latest funding round | Latest funding round $ 25m (almost 16 years ago) | Latest funding round $ 546.4k (almost 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 25m | Total funding raised $ 546.4k | Total funding raised $ 94m |
For sources of this data, please see the company profile
View Company Profiles
Reglagene
HQ
Tucson, US
Employees
14
Reglagene is a company that discovers and develops noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment.
View companyExicure
HQ
Skokie, US
Employees
29
Exicure is a biotechnology company developing immunomodulatory and gene regulating drugs against validated targets.
View company